JY BioMed is advancing a hair follicle-derived mesenchymal stem cell (HF-MSC) platform, offering a novel, minimally invasive source for regenerative and immune-modulatory applications. HF-MSCs demonstrate multipotent differentiation capacity and secrete a range of bioactive factors that may support tissue repair, inflammatory regulation, and skin health.

​

Complementing the cell-based program, we are also investigating HF-MSC-derived exosomes as a next-generation, cell-free therapeutic approach. These exosomes are being explored for their potential roles in promoting tissue regeneration, modulating immune responses, and supporting the maintenance of skin and hair follicle integrity.

​

All HF-MSC and exosome research is conducted under preclinical frameworks, with an emphasis on scalable production, quality consistency, and regulatory alignment to support future clinical translation.